ScreenerHero

MENS Jyong Biotech Ltd.

NAS · US · Healthcare · Biotechnology · jyongbio.com
2.060USD+1.98%Mkt Cap: 156.62M $P/E: —

Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, a…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap156.62M USD
Enterprise Value167.33M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-4.67M USD
Revenue/Share—
Last Price2.060 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees27
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-66.74
EV/Revenue—
P/S—
P/B-6.01
EPS (TTM)-0.06
EPS (Forward)—
52W Range
1.4301% of range63.00
52W High63.00 USD
52W Low1.430 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE18.75%
ROA-22.48%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.04M USD
CapEx (TTM)—
FCF Margin—
FCF Yield2.80%
Net Debt17.37M USD
Net Debt/EBITDA-6.93
Balance Sheet
Debt/Equity-0.74
Current Ratio0.45
Quick Ratio0.03
Book Value/Sh-0.34 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.74.23M
Float26.94M
Insiders62.20%
Institutions0.76%
Short Interest
Short Ratio6.5d
Short % Float0.59%
Short % Out.0.33%
Shares Short245.33K
Short (prev mo.)177.22K
Technical
SMA 502.139 (-3.7%)
SMA 2002.315 (-11.0%)
Beta—
S&P 52W Chg15.78%
Avg Vol (30d)44.25K
Avg Vol (10d)48.71K
Technical Indicators
RSI (14)47.7
MACD-0.0284
MACD Signal-0.0250
MACD Hist.-0.0034
BB Upper2.262 USD
BB Middle2.082 USD
BB Lower1.902 USD
BB Width17.30%
ATR (14)0.1753 USD
Vol Ratio (20d)0.55x